sodium tungstate
Small moleculeexperimental
Sodium tungstate is the inorganic compound with the formula Na2WO4. This white, water-soluble solid is the sodium salt of tungstic acid. It is useful as a source of tungsten for chemical synthesis. It is an intermediate in the conversion of tungsten ores to the metal. — Wikipedia
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2007 (NCT00555074)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
- Mol. weight
- 293.82 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- Yes
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaSodium tungstate ↗
- ChEMBLCHEMBL85943 ↗
Also known as
- sodium tungstate
- sodium tungstate
- sodium tungstate
- sodium tungstate dihydrate
- sodium tungstate(vi)
- sodium tungstate(vi), 181w-labeled
- sodium tungstate(vi) dihydrate
- tungstic acid (h2wo4), disodium salt
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00555074 | Phase 2 | Nov 1, 2007 | Fundació ACE, University of Barcelona |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fundació ACE | Academic/Hospital | 1 | 0 | 1 | 2007 |
| University of Barcelona | Academic/Hospital | 1 | 1 | 1 | 2007 |
2 organizations
Page 1 / 1